Valuation: GC Genome Corporation

Market Cap 183B 136M 124M 114M 104M 195M 12.6B 205M 1.39B 553M 6.88B 511M 500M 21.6B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 123M 91.82K 83.63K 77.06K 70.1K 132K 8.5M 138K 938K 373K 4.64M 345K 337K 14.58M EV / Sales 2026 *
3.16x
EV / Sales 2027 * 2.33x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-5.97%
1 week-8.10%
Current month-15.16%
1 month-17.43%
3 months+35.68%
6 months+11.24%
Current year+13.20%
1 week 7,500
Extreme 7500.00000000
8,680
1 month 6,000
Extreme 6000
10,310
Current year 4,100
Extreme 4100
10,480
1 year 4,100
Extreme 4100
10,480
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 2020-03-25
Director of Finance/CFO 50 2025-03-26
Comptroller/Controller/Auditor 45 2024-03-28
Director TitleAgeSince
Director/Board Member 57 2023-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/17/25 Free

Chief Executive Officer

169,285 -
6/17/25 Free 138,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-5.97%-8.10%+21.38% - 146M
+1.02%-9.61%+6.21%+18.31% 102B
+3.32%-4.96%-0.41%+90.94% 96.16B
-5.72%-14.52%+20.93%+397.81% 42.04B
-4.76%+0.13%+14.29%+95.31% 32.01B
-0.36%-0.97%+40.32%+73.80% 29.95B
-0.30%-0.62%+37.51%+91.31% 28.5B
-0.06%-7.94%+41.05%+305.42% 20.98B
-0.62%-2.67%-16.84%-20.10% 19.4B
0.00%+0.77%-4.24%+32.77% 16.97B
Average -1.44%-4.26%+16.02%+120.62% 39B
Weighted average by Cap. -0.15%-6.58%+12.03%+107.57%

Financials

2026 *2027 *
Net sales 39B 29.07M 26.48M 24.4M 22.19M 41.63M 2.69B 43.76M 297M 118M 1.47B 109M 107M 4.61B 48.8B 36.38M 33.13M 30.53M 27.77M 52.1M 3.37B 54.75M 372M 148M 1.84B 136M 134M 5.77B
Net income - -
Net Debt -59.4B -44.28M -40.33M -37.16M -33.8M -63.41M -4.1B -66.65M -452M -180M -2.24B -166M -163M -7.03B -68.8B -51.28M -46.71M -43.04M -39.15M -73.45M -4.75B -77.19M -524M -208M -2.59B -192M -188M -8.14B
Projected Income Statement - Annual - GC Genome Corporation
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
26-11-19 ₩7,720.00 -5.97% 224,970
26-11-19 ₩8,210.00 +2.62% 167,032
26-11-18 ₩8,000.00 +4.99% 292,976
26-11-17 ₩7,620.00 -3.67% 214,400
26-11-16 ₩7,910.00 -7.49% 240,816

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GC Genome Corporation
  1. Stock Market
  2. Stocks
  3. A340450 Stock